The committee will provide a status update on its approach to emergency use authorization (EUA) for COVID-19 vaccines intended for use in individuals 12 through 17 years of age. The committee will also discuss the data needed to support an EUA and a biologics license application (BLA) for a COVID-19 vaccine intended for use in children less than 12 years of age. The committee will not discuss any specific products.
Back to All Events
Earlier Event: June 9
Pharmacy Compounding Advisory Committee
Later Event: June 24
Oncologic Drugs Advisory Committee